1887

Abstract

The ability to aggregate human platelets was examined for five strains and five subsp. strains isolated from patients with infective endocarditis (IE), 25 laboratory isolates from the same two species, and 14 strains from five other oral species, namely and Amongst the strains, platelets were aggregated by all five IE strains and 8/16 laboratory strains. For the subsp. strains, the respective numbers were 2/5 and 2/9. Aggregation also occurred with 11/14 strains of the other five species; each species was represented. The optimal ratio of bacteria to platelets for aggregation was approximately 1:1, and there was considerable variation in the lag phase that preceded aggregation, depending on the source of the platelets. Overall, the lag phase varied between 0·25±01·and 20·4±3·2 min and the percentage aggregation ranged between 70±2·6 and 104±13·5%. Confirmation that aggregation was being observed came from studies with five strains on the inhibitory effects of EDTA, dipyridamole, apyrase, imipramine, acetylsalicylic acid and quinacrine. Inhibition of aggregation by strains by the peptide arginine-glycine-aspartic acid-serine (RGDS) further indicated a role for fibronectin and/or fibrinogen. Pronase treatment of cells for 1 h and extraction of bacterial surface components with 0·1 -Tris/HCl (pH 8·5) at 37 °C for 1 h stopped aggregation in 8/9 IE strains. Extracted surface proteins (200 μg) completely inhibited platelet aggregation by 8/9 of the homologous strains. A comparison of the platelets from four donors showed that an increase in the lag phase by 50% required 11·5, 14·8, 33·3 or 115 μg of extract, indicating a variability in donor response to aggregation by lactobacilli. The data indicate that platelet aggregation by lactobacilli may be an important contributory factor in IE. The potential to cause IE is present in the general population of oral lactobacilli and due regard should be taken when strain selection is made for probiotic purposes.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-139-12-2945
1993-12-01
2021-05-18
Loading full text...

Full text loading...

/deliver/fulltext/micro/139/12/mic-139-12-2945.html?itemId=/content/journal/micro/10.1099/00221287-139-12-2945&mimeType=html&fmt=ahah

References

  1. Abstracts of the XVII International Congress on Microbial Ecology and Disease Helsinki, Finland 28–29August 1992 Microbial Ecology in Health and Disease 5i–xxii
    [Google Scholar]
  2. Axelrod J., Keusch G.T., Bottone E., Cohen S.M., Hirschman S.Z. 1973; Endocarditis caused by Lactobacillus plantarum. Annals of Internal Medicine 7:33–37
    [Google Scholar]
  3. Bradford M.M. 1976; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248–254
    [Google Scholar]
  4. Chomarat M., Espinouse D. 1991; Lactobacillus rhamnosus septicemia in patients with prolonged aplasia receiving ceftazidime- vancomycin. European Journal of Clinical Microbiology & Infectious Diseases 10:44
    [Google Scholar]
  5. Chong Y., Lim H.S., Lee S.Y., Cho S.Y. 1991; Lactobacillus casei subspecies casei endocarditis - a case report. Yonsei Medical Journal 32:69–73
    [Google Scholar]
  6. Clawson C.C., White J.G. 1971; Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. American Journal of Pathology 82:367–380
    [Google Scholar]
  7. Cox R.P., Thomsen J.K. 1990; Computer-aided identification of lactic acid bacteria using the API 50 CHL system. Letters in Applied Bacteriology 10:257–259
    [Google Scholar]
  8. Czuprynski C.J., Balish E. 1981; Interaction of rat platelets with Listeria monocytogenes. Infection and Immunity 33:103–108
    [Google Scholar]
  9. Davies A.J., James P.A., Hawkey P.M. 1986; Lactobacillus endocarditis. Journal of Infection 12:169–174
    [Google Scholar]
  10. Douglas C.W.I., Brown P.R., Preston F.E. 1990; Platelet aggregation by oral streptococci. FEMS Microbiology Letters 72:63–68
    [Google Scholar]
  11. Forrester L.J., Campbell B.J., Berg N.N., Barrett J.T. 1985; Aggregation of platelets by Fusobacterium necrophorum. Journal of Clinical Microbiology 22:245–249
    [Google Scholar]
  12. Gartner T.K., Bennett J.S. 1985; The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. Journal of Biological Chemistry 260:11891–11894
    [Google Scholar]
  13. Harty D.W.S., Knox K.W. 1991; An in vitro study of adhesion of various Lactobacillus species. Microbial Ecology in Health and Disease 4:19–28
    [Google Scholar]
  14. Harty D.W.S., Patrikakis M., Knox K.W. 1993; The identification of Lactobacillus strains isolated from patients with infective endocarditis and comparison of their surface associated properties with those of other strains from the same species. Microbial Ecology in Health and Disease 6:191–201
    [Google Scholar]
  15. Hawiger J., Steckley S., Hammond D., Cheng C., Timmons S., Des Prez R.M. 1979; Staphylococci-induced human platelet injury mediated by protein A and IgG Fc fragment receptor. Journal of Clinical Investigation 64:931–937
    [Google Scholar]
  16. Herzberg M.C., Brintzenhofe K.L. 1983; ADP-like platelet aggregation activity generated by viridans streptococci incubated with exogenous ATP. Infection and Immunity 40:120–125
    [Google Scholar]
  17. Herzberg M. C., Brintzenhofe K. L., Clawson C. C. 1983a; Aggregation of human platelets and adhesion of Streptococcus sanguis. Infection and Immunity 39:1457–1469
    [Google Scholar]
  18. Herzberg M. C., Brintzenhofe K. L., Clawson C. C. 1983 b; Cell-free released components of Streptococcus sanguis inhibit human platelet aggregation. Infection and Immunity 42:394–401
    [Google Scholar]
  19. Herzberg M.C., Erickson P.R., Kane P.K., Clawson D.J., Clawson C.C., Hoff F.A. 1990; Platelet-interactive products of Streptococcus sanguis protoplasts. Infection and Immunity 58:4117–4125
    [Google Scholar]
  20. Herzberg M.C., Macfarlane G.D., Gong K., Armstrong N.N., Witt A.R., Erickson P.R., Meyer M.W. 1992; The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis. Infection and Immunity 60:4809–1818
    [Google Scholar]
  21. Horose M., Kiyoyama H., Ogawa H., Shinjo T. 1992; Aggregation of bovine platelets by Fusobacterium necrophorum. Veterinary Microbiology 32:343–350
    [Google Scholar]
  22. Isogai E., Isogai H., Yokota K., Hayashi S., Fujii N., Oguma K., Yoshikawa K., Sasamoto Y., Kotake S., Ohno S. 1991; Platelet aggregation induced by uncommon serotypes of Streptococcus sanguis isolated from patients with Behqet’s disease. Archives of Oral Biology 36:425–129
    [Google Scholar]
  23. Knox K.W., Hunter N. 1991; The role of oral bacteria in the pathogenesis of infective endocarditis. Australian Dental Journal 36:286–292
    [Google Scholar]
  24. Laemmli U.K., Favre M. 1973; Maturation of the head of bacteriophage T4. 1. DNA packaging events. Journal of Molecular Biology 80:579–599
    [Google Scholar]
  25. Manning J.E., Hume E.B.H., Hunter N., Knox K.W. 1993; An analysis of the virulence factors associated with streptococcal endocarditis. Journal of Medical Microbiology in the Press
    [Google Scholar]
  26. Maskell R., Pead L. 1992; 4-Fluoroquinolones and Lactobacillus spp as emerging pathogens. Lancet 339:929
    [Google Scholar]
  27. Mills D.C.B., Roberts G.C.K. 1967; Membrane active drugs and the aggregation of human platelets. Nature; London: 21335–38
    [Google Scholar]
  28. Naudé W.D.T., Swanepoel A., Bohmer R.H., Bolding E. 1988; Endocarditis caused by Lactobacillus casei subspecies rhamnosus. South African Medical Journal 73:612–614
    [Google Scholar]
  29. Reniero R., Morelli L., Callegari M.L., Sommi P., Bottazzi V. 1990; Surface proteins in enteric lactobacilli. Annali di Microbiologica ed Enzimologica 40:83–91
    [Google Scholar]
  30. Sharpe M.E., Hill L.R., Lapage S.P. 1973; Pathogenic lactobacilli. Journal of Medical Microbiology 6:281–286
    [Google Scholar]
  31. Sheld W.M. 1984; Pathogenesis and pathophysiology of infective endocarditis. In Endocarditis pp. 1–32 Edited by Sande M. A., Kaye D, Root K. New York: Churchill Livingstone;
    [Google Scholar]
  32. Sheth N.K., Kurup V.P., Barron B.A. 1980; The role of Aspergillus fumigatus antigens in blood coagulation and platelet function. Microbios 28:91–96
    [Google Scholar]
  33. Simonet M., Triadou P., Frehel C., Morel-Kopp M.-C., Kaplan C., Berche P. 1992; Human platelet aggregation by Yersinia pseudotuberculosis is mediated by invasin. Infection and Immunity 60:366–373
    [Google Scholar]
  34. Skerl K.G., Calderone R.A., Sreevalsan T. 1981; Platelet interactions with Candida albicans. Infection and Immunity 34:938–943
    [Google Scholar]
  35. Struve J., Weiland O., Nord C.E. 1988; Lactobacillus plantarum endocarditis in a patient with benign monoclonal gammopathy. Journal of Infection 17:127–130
    [Google Scholar]
  36. Sullam P.M., Valone F.H., Mills J. 1987; Mechanisms of platelet aggregation by viridans group streptococci. Infection and Immunity 55:1743–1750
    [Google Scholar]
  37. Sussman J.L, Baron E.J., Goldberg S.M., Kaplan M.H., Pizzarello R.A. 1986; Clinical manifestations and therapy of Lactobacillus endocarditis: report of a case and a review of the literature. Reviews of Infectious Diseases 8:771–776
    [Google Scholar]
  38. Usui Y., Ohshima Y., Yoshida K. 1987; Platelet aggregation by group B streptococci. Journal of General Microbiology 133:1593–1600
    [Google Scholar]
  39. Usui Y., Ichiman Y., Suganuma M., Yoshida K. 1991; Platelet aggregation by strains of enterococci. Microbiology and Immunology 35:933–942
    [Google Scholar]
  40. Wood E.G., Gray B.M. 1986; Type-specific antibody prevents platelet aggregation induced by group B streptococci type III. Journal of Laboratory and Clinical Medicine 107:322–326
    [Google Scholar]
  41. Yeaman M.R., Norman D.C., Bayer A.S. 1992; Staphylococcus aureus susceptibility to thrombin-induced platelet microbicidal protein is independent of platelet adherence and aggregation in vitro. Infection and Immunity 60:2368–2374
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-139-12-2945
Loading
/content/journal/micro/10.1099/00221287-139-12-2945
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error